Predictors of sputum eosinophilia in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020
Sputum eosinophilia in patients with chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 585s Year: 2007
Induced sputum concentrations of mucin in patients with asthma and chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 61s Year: 2007
Sputum eosinophilia in the diagnosis and management of asthma of moderate severity in adults Source: Eur Respir J 2007; 30: Suppl. 51, 587s Year: 2007
Induced sputum in children with mild-to-moderate atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
Sputum eosinophils and bronchial hyperreactivity in patients with chronic cough Source: Eur Respir J 2005; 26: Suppl. 49, 479s Year: 2005
Inflammatory markers in sputum of patients with cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Asthma and persistent low sputum eosinophilia Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Longitudinal variability of pulmonary function and sputum eosinophilia in severe refractory asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003
Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001
Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 594s Year: 2004
Bronchial challenge test in patients with chronic persistent cough and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 475s Year: 2003
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020
Induced sputum to assess bronchial inflammation in children with intermittent athopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Treating rhinitis in patients with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 425s Year: 2001
Induced sputum eosinophils, bronchial reactivity and cough sensitivity in allergic rhinitis patients Source: Eur Respir J 2005; 26: Suppl. 49, 583s Year: 2005
Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019
Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017